Enterome, AbbVie to Collaborate On Crohn’s Disease Gut Microbiome Monitor

Enterome, AbbVie to Collaborate On Crohn’s Disease Gut Microbiome Monitor
ENTEROME Bioscience SA, a company currently developing new drugs and diagnostic tools for microbiome-related disorders, recently announced a key collaboration with AbbVie. The partnership aims to develop further diagnostic products to support personalized therapies and drugs for the treatment of diseases linked to microbiome composition alterations, including Inflammatory Bowel Diseases (IBD) and metabolic diseases. As part of the

Knowledge is power when living with IBD.

Get access to the web’s leading IBD news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *